Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David W. Nassif currently holds 120,300 shares of Sio Gene Therapies Inc. (SIOX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David W. Nassif has been a net seller of SIOX stock. They have purchased $0 and sold $501.6K worth of shares.
David W. Nassif's most recent insider trade was on May 21, 2026, when they sold 10,000 shares at $30.31 per share.
David W. Nassif serves as Executive at Sio Gene Therapies Inc. (SIOX). They have executed 10 insider transactions totaling $501.6K over their tenure at the company.
David W. Nassif holds the position of Executive at Sio Gene Therapies Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
David W. Nassif has shown a selling trading pattern, with $0 in total purchases and $501.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David W. Nassif was on May 21, 2026, when they sold $303.1K worth of PHVS shares. This transaction involved 10,000 shares at $30.31 per share.
David W. Nassif currently owns 120,300 shares of Sio Gene Therapies Inc. (SIOX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David W. Nassif's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David W. Nassif has 10 Form 4 filings on record as an insider at Sio Gene Therapies Inc..
Set alerts for David W. Nassif and 40,000+ other insiders.